Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2017 | Involving patients in clinical trial design: a message to academia and industry

Jan Geissler • 24 Jun 2017
EHA 2017
Chronic Myeloid Leukemia General

Jan Geissler from CML Advocates Network calls out to academia and industry to create and implement structured operating procedures so that patient values and patient-centric outcomes are part of initial clinical trial design. This video was recorded at the European Society of Hematology congress in Madrid, Spain.

More from Jan Geissler

1:21
The need for patient advocates to attend major congresses such as EBMT
Jan Geissler • 24 Mar 2019
1:14
The evolution of patient advocacy
Jan Geissler • 24 Mar 2019
1:28
The importance of patient advocacy tracks at congresses
Jan Geissler • 24 Mar 2019
0:53
The aims of the Patvocates Network
Jan Geissler • 24 Mar 2019

Related Videos

4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals